James Drake

1.3k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

James Drake is a scholar working on Rheumatology, Molecular Biology and Oncology. According to data from OpenAlex, James Drake has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in James Drake's work include Heterotopic Ossification and Related Conditions (5 papers), Genetic Syndromes and Imprinting (3 papers) and Parathyroid Disorders and Treatments (3 papers). James Drake is often cited by papers focused on Heterotopic Ossification and Related Conditions (5 papers), Genetic Syndromes and Imprinting (3 papers) and Parathyroid Disorders and Treatments (3 papers). James Drake collaborates with scholars based in United States, United Kingdom and Malaysia. James Drake's co-authors include Christopher M. Lauderback, Alessandra Castegna, David Cholok, Shuli Li, Shawn Loder, Benjamin Lévi, Shailesh Agarwal, Jean L. Grem, Carmen J. Allegra and J C Swan and has published in prestigious journals such as PLoS ONE, Cancer and Scientific Reports.

In The Last Decade

James Drake

20 papers receiving 981 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1

2002 581 citations Alessandra Castegna, Christopher M. Lauderback et al. Neurobiology of Aging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Drake United States	14	339	339	154	125	124	20	1.0k
Andrew MacKenzie United Kingdom	19	540 1.6×	229 0.7×	105 0.7×	86 0.7×	70 0.6×	32	1.1k
Nagavedi S. Umapathy United States	24	628 1.9×	219 0.6×	64 0.4×	160 1.3×	104 0.8×	32	1.3k
Jai Youl Ro South Korea	24	516 1.5×	377 1.1×	113 0.7×	108 0.9×	102 0.8×	65	1.5k
Hiromi Nochi Japan	20	724 2.1×	229 0.7×	57 0.4×	170 1.4×	72 0.6×	40	1.3k
R C O Zanardo Canada	10	306 0.9×	413 1.2×	71 0.5×	45 0.4×	94 0.8×	12	1.4k
Germán Gallardo Spain	8	801 2.4×	147 0.4×	52 0.3×	104 0.8×	90 0.7×	10	1.5k
Su Xu United Kingdom	21	591 1.7×	240 0.7×	80 0.5×	110 0.9×	110 0.9×	31	1.4k
Perle Totoson France	16	220 0.6×	144 0.4×	186 1.2×	50 0.4×	72 0.6×	47	808
Linda Connelly United States	18	669 2.0×	307 0.9×	60 0.4×	393 3.1×	79 0.6×	23	1.7k
Song Jin China	20	646 1.9×	85 0.3×	129 0.8×	110 0.9×	79 0.6×	51	1.3k

Countries citing papers authored by James Drake

Since Specialization

Citations

This map shows the geographic impact of James Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Drake more than expected).

Fields of papers citing papers by James Drake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Drake. The network helps show where James Drake may publish in the future.

Co-authorship network of co-authors of James Drake

This figure shows the co-authorship network connecting the top 25 collaborators of James Drake. A scholar is included among the top collaborators of James Drake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Drake. James Drake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agarwal, Shailesh, Shawn Loder, Christopher Breuler, et al.. (2017). Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification. Molecular Therapy. 25(8). 1974–1987. 40 indexed citations

Agarwal, Shailesh, Shawn Loder, David Cholok, et al.. (2016). Local and Circulating Endothelial Cells Undergo Endothelial to Mesenchymal Transition (EndMT) in Response to Musculoskeletal Injury. Scientific Reports. 6(1). 32514–32514. 25 indexed citations

Agarwal, Shailesh, David Cholok, Shawn Loder, et al.. (2016). mTOR inhibition and BMP signaling act synergistically to reduce muscle fibrosis and improve myofiber regeneration. JCI Insight. 1(20). e89805–e89805. 25 indexed citations

Agarwal, Shailesh, James Drake, Ammar T. Qureshi, et al.. (2016). Characterization of Cells Isolated from Genetic and Trauma-Induced Heterotopic Ossification. PLoS ONE. 11(8). e0156253–e0156253. 16 indexed citations

Agarwal, Shailesh, Shawn Loder, David Cholok, et al.. (2016). Surgical Excision of Heterotopic Ossification Leads to Re-Emergence of Mesenchymal Stem Cell Populations Responsible for Recurrence. Stem Cells Translational Medicine. 6(3). 799–806. 43 indexed citations

Agarwal, Shailesh, Shawn Loder, John Li, et al.. (2015). Diminished Chondrogenesis and Enhanced Osteoclastogenesis in Leptin-Deficient Diabetic Mice ( ob/ob ) Impair Pathologic, Trauma-Induced Heterotopic Ossification. Stem Cells and Development. 24(24). 2864–2872. 18 indexed citations

Brooks, Sandra E., Steven C. Plaxe, Karen Basen‐Engquist, et al.. (2014). Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer. Gynecologic Oncology. 133. 39–40. 1 indexed citations

Han, Kyu-Yeon, Suhair Sunoqrot, James Drake, et al.. (2013). Nanotechnology in Corneal Neovascularization Therapy—A Review. Journal of Ocular Pharmacology and Therapeutics. 29(2). 124–134. 42 indexed citations

Castegna, Alessandra, et al.. (2002). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1. Neurobiology of Aging. 23(5). 655–664. 581 indexed citations breakdown →

10.

Grem, Jean L., Kathleen D. Danenberg, K A Behan, et al.. (2001). Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.. PubMed. 7(4). 999–1009. 59 indexed citations

11.

Pinelli, D., James Drake, Mark Williams, D Cavanagh, & Jeanne L. Becker. (1998). Hormonal modulation of ishikawa cells during three-dimensional growth in vitro☆. Journal of the Society for Gynecologic Investigation. 5(4). 217–223. 9 indexed citations

12.

Johnston, Patrick G., et al.. (1996). The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line. European Journal of Cancer. 32(12). 2148–2154. 28 indexed citations

13.

Drake, James, et al.. (1996). A reply:. British Journal of Clinical Pharmacology. 42(5). 646–647. 1 indexed citations

14.

Grem, Jean L., James Drake, Francois J. Geoffroy, et al.. (1994). Cytotoxicity and metabolism of 4-methoxy-8-(β-d-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cells. Biochemical Pharmacology. 48(11). 2117–2126. 1 indexed citations

15.

McAtee, Nanette, et al.. (1993). A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.. PubMed. 53(20). 4828–36. 19 indexed citations

16.

Drake, James, et al.. (1991). COMPARATIVE PHARMACOKINETICS OF TEMAZEPAM GELTHIX AND LIQUID-FILLED SOFT GELATIN CAPSULES. Journal of Clinical Pharmacy and Therapeutics. 16(5). 345–351. 2 indexed citations

17.

Kovacs, Joseph A., C J Allegra, Susan Kennedy, et al.. (1988). Efficacy of Trimetrexate, a Potent Lipid-Soluble Antifolate, in the Treatment of Rodent Pneumocystis Carinii Pneumonia. American Journal of Tropical Medicine and Hygiene. 39(5). 491–496. 20 indexed citations

18.

Kovacs, Joseph A., Carmen J. Allegra, Bruce A. Chabner, et al.. (1987). Potent Effect of Trimetrexate, a Lipid-Soluble Antifolate, on Toxoplasma gondii. The Journal of Infectious Diseases. 155(5). 1027–1032. 44 indexed citations

19.

Goldberg, Nelson H., et al.. (1978). Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate. Cancer. 41(1). 52–55. 35 indexed citations

20.

Drake, James, et al.. (1965). Gastric Carcinoma in the Dog, Two Further Cases. Journal of Small Animal Practice. 6(2). 131–133. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact